The strong operational turnaround and U.S. commercial momentum are positive signals, but results are preliminary and unaudited. Monitor upcoming full-year filings for confirmation and any regulatory clearances for new products.
Price Chart
Executive Summary
Baird Medical reported preliminary H1 2026 revenue of $9.9M (+24.6% YoY) and swung to a net profit of $14K from an $11.4M loss, driven by U.S. expansion and cost reductions. Gross margin improved to 87.0% and adjusted EBITDA turned positive at $4.0M. The turnaround is significant for the small-cap medtech, but results are preliminary and unaudited.
Key Financial Metrics
Key Facts
- H1 2026 revenue $9.9M vs $8.0M in H1 2025, +24.6% YoY
- Net income $14K vs net loss of $11.4M in prior year period
- Gross margin 87.0% vs 82.1% YoY
- EBITDA $1.6M vs -$9.7M; Adjusted EBITDA $4.0M vs -$3.3M
- U.S. revenue contributed ~27% of total vs <2% in H1 2025
Financial Impact
Revenue growth of 24.6% and swing from $11.4M net loss to $14K net profit; EBITDA improved by $11.3M
Risk Factors
- Preliminary and unaudited results subject to year-end adjustments
- Small market cap ($47M) with limited liquidity
- Reliance on continued U.S. expansion and regulatory approvals
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3355821 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 26d ago | 6-K | $0.7440 | awaiting T+20 | — | $0.4277 (+42.51%) |
Sep 30, 2026 26d ago | 6-K | $0.7800 | awaiting T+20 | — | $0.4277 (−45.17%) |
Sep 3, 2026 7w ago | 6-K | $1.17 $0.7511 | ▼ −35.80% | ▼ −34.62% | $0.4277 (−63.44%) |
Sep 3, 2026 7w ago | Press Release | $1.17 $0.7511 | ▼ −35.80% | ▼ −34.62% | $0.4277 (−63.44%) |
Aug 18, 2026 9w ago | EFFECT | $1.09 $1.06 | ▲ +2.75% | ▲ +1.76% | $0.4277 (+60.76%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers